Melody Yin
Yue “Melody” Yin
Clinical Trial Manager | Eikon Therapeutics
Originally from China, Yue “Melody” Yin moved to the United States at 15 years old in 2001 and overcame numerous challenges while learning English and assimilating into American society. She ultimately became bilingual and fluent in both Mandarin and English and excelled in the classroom—her multicultural background, she believes, significantly contributed to her adaptability and maturity. Her journey into healthcare was shaped largely by the loss of her grandfather from lung cancer when she was in high school, inspiring her to devote herself to cancer research and make a difference in people’s lives.
Upon earning a Bachelor of Arts in molecular and cellular biology from the University of California, Berkeley, where she covered her tuition through a scholarship, Ms. Yin decided she wanted to pursue a master’s degree in public health. Her mother and husband supported her in her move from California to study at the University of Michigan, where she served as a research assistant in the School of Public Health before earning her degree in molecular and hospital epidemiology in 2012. From there, she launched her career as a clinical research coordinator at Oregon Health & Science University and Stanford University. She subsequently advanced from a clinical trial associate at Vascular Dynamics, Inc. and a senior clinical trial associate at Revance Aesthetics.
Between 2020 and 2024, Ms. Yin served as a senior associate study manager at DOCS, now ICON Strategic Solutions and a clinical team manager of hematology, oncology, and general medicine at Thermo Fisher Scientific, Inc. She’s currently active as a clinical trial manager of oncology at Eikon Therapeutics, where she conducts oncology and cancer research, performs clinical trials for developing new treatments for cancer, works with hospitals to administer drugs to patients, and assess any potential side effects and efficacy in treating the targeted disease. She’s further dedicated to her field as a longtime member of the Association of Clinical Research Professionals and Society of Clinical Research Associates.
Ms. Yin’s primary objective is to ensure the success of all the clinical trials she is conducting, but, looking toward the future, she aims to develop herself into a great leader. Her previous experience of working with remarkable leaders has had a profound impact on her life and she aspires to become like them one day.
Press Release
Marquis Who’s Who Honors Yue “Melody” Yin for Expertise in Pharmaceuticals and Biotechnology
Yue “Melody” Yin is an expert in clinical trial research in the pharmaceuticals and biotechnology industry
MILPITAS, CA, October 24, 2024 —
Yue “Melody” Yin has been selected for inclusion in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Ms. Yin is a distinguished clinical trial manager at Eikon Therapeutics, where she ensures the successful collection and validation of clinical data during clinical trials. Her responsibilities in clinical trial operations and management, include developing study documentation, working with hospital sites to administer drugs to patients and assessing potential side effects or the efficacy of treatments for targeted diseases. Her expertise in clinical trial research is evident through her meticulous approach and dedication to advancing medical science.
Ms. Yin’s career journey began as a research assistant at the School of Public Health, University of Michigan, from 2011 to 2012. She then served as a clinical research coordinator at Oregon Health & Science University from 2013 to 2014, followed by a similar role at Stanford University in 2016. Her experience expanded as she took on the position of clinical trial associate at Vascular Dynamics Inc. from 2017 to 2018. Subsequently, she became a senior clinical trial associate at Revance Therapeutics from 2019 to 2020.
In 2020, Ms. Yin joined DOCS (now ICON Strategic Solutions) as a senior associate study manager, where she worked until 2021. She then transitioned to Thermo Fisher Scientific Inc., serving as a clinical team manager in hematology and oncology from 2021 to 2023 and later in general medicine from 2023 to 2024. Her current role at Eikon Therapeutics began in 2024, where she continues to make significant contributions to oncology research in Asia.
Ms. Yin’s academic background is equally impressive. She earned a Bachelor of Arts in molecular and cellular biology from the University of California, Berkeley, in 2008. During her time there, she was proud to have covered her tuition through scholarships, reflecting her determination and dedication to education. She furthered her studies with a Master of Public Health in molecular and hospital epidemiology from the School of Public Health at the University of Michigan in 2012.
Ms. Yin’s professional certifications include the Association of Clinical Research Professionals Certified Professional (ACRP-CP), obtained in 2022, the Certified Clinical Research Professional (CCRP) from the Society of Clinical Research Associates in 2020, and a Clinical Research Conduct and Management Certificate from the University of California, Berkeley, in 2016.
As an active member of the Association of Clinical Research Professionals and the Society of Clinical Research Associates since 2016, Ms. Yin continues to stay engaged with industry developments and contribute to the field of clinical research.
Ms. Yin attributes her success to the support and encouragement of her mentors, mother and husband. Inspired by their belief in her potential and motivated by personal experiences such as the loss of her grandfather due to lung cancer, she has dedicated herself to making meaningful contributions to cancer research. Her passion for health care drives her work in developing new drugs and therapies for cancer patients.
Outside of her professional life, Ms. Yin enjoys reading biographies and visiting national parks. Born in Shanghai, she finds inspiration in books that have transformed her life and helped her persist in pursuing what is important to her. Her primary objective remains ensuring the success of all clinical trials she conducts while aspiring to develop into a great leader influenced by the remarkable people she has worked with throughout her career.